Neogen (NEOG) Projected to Announce Earnings on Thursday

Neogen (NASDAQ:NEOG) is expected to be announcing its Q4 2026 results before the market opens on Thursday, July 30th. Analysts expect Neogen to announce earnings of $0.05 per share and revenue of $212.35 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:00 AM ET.

Neogen Stock Down 1.0%

Shares of NASDAQ NEOG opened at $9.83 on Thursday. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. The stock has a market capitalization of $2.14 billion, a PE ratio of -3.51, a P/E/G ratio of 4.45 and a beta of 1.80. Neogen has a one year low of $4.56 and a one year high of $11.43. The business’s fifty day moving average price is $9.23 and its 200-day moving average price is $9.53.

Hedge Funds Weigh In On Neogen

Large investors have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new stake in Neogen during the 4th quarter worth about $138,000. T. Rowe Price Investment Management Inc. grew its holdings in Neogen by 249.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company’s stock valued at $57,191,000 after buying an additional 5,838,570 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in Neogen by 10.1% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,837 shares of the company’s stock valued at $125,000 after buying an additional 1,638 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of Neogen by 1.0% during the fourth quarter. Mackenzie Financial Corp now owns 7,898,439 shares of the company’s stock valued at $55,574,000 after buying an additional 79,010 shares during the period. Finally, Tudor Investment Corp ET AL increased its position in shares of Neogen by 4,902.6% during the fourth quarter. Tudor Investment Corp ET AL now owns 539,326 shares of the company’s stock valued at $3,770,000 after buying an additional 528,545 shares during the period. 96.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a research note on Wednesday, July 8th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $10.67.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.